Significantly improve survival and quality of life of cancer patients across the world
WIN Consortium in cancer personalized medicine is dedicated to significantly improving the survival and quality of life for cancer patients worldwide. Through global collaboration, WIN Consortium unites academic cancer centers, industries, and patient organizations across continents to pioneer innovative strategies and tools in precision oncology.
Based in Villejuif, Val de Marne, France, at 9 rue Guy Môquet, Villejuif, Val de Marne 94800, FR, WIN Consortium focuses on conducting proof-of-concept trials, sharing cutting-edge research, and promoting the adoption of personalized cancer medicine on a global scale. WIN Consortium's commitment to innovation is evident through groundbreaking trials such as WINTHER and SPRING_01, which explore novel approaches to enhance the efficacy of cancer treatments and improve patient outcomes.
The WIN Consortium in cancer personalized medicine continues to expand its reach and impact in the field of oncology. We invite the manager of WIN Consortium in cancer personalized medicine to create a customized and exclusive company showcase and product listing on our platform to further highlight their contributions and advancements in personalized cancer medicine.
WIN Consortium dans le domaine de la médecine personnalisée du cancer se consacre à améliorer de manière significative la survie et la qualité de vie des patients atteints de cancer dans le monde entier. Grâce à une collaboration mondiale, WIN Consortium réunit des centres universitaires de cancérologie, des industries et des organisations de patients à travers les continents pour lancer des stratégies et des outils innovants en oncologie de précision.
Basé à Villejuif, Val de Marne, France, au 9 rue Guy Môquet, Villejuif, Val de Marne 94800, FR, WIN Consortium se concentre sur la réalisation d'essais de validation de principe, le partage de recherches de pointe et la promotion de l'adoption de la médecine personnalisée du cancer à l'échelle mondiale. L'engagement de WIN Consortium envers l'innovation est évident à travers des essais novateurs tels que WINTHER et SPRING_01, qui explorent de nouvelles approches pour améliorer l'efficacité des traitements contre le cancer et améliorer les résultats pour les patients.
Le WIN Consortium dans le domaine de la médecine personnalisée du cancer continue d'étendre sa portée et son impact dans le domaine de l'oncologie. Nous invitons le responsable de WIN Consortium dans le domaine de la médecine personnalisée du cancer à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre davantage en évidence leurs contributions et leurs progrès en matière de médecine personnalisée du cancer.
Compare WIN Consortium in cancer personalized medicine with 3 companies in Hospitals-and-Health-Care
| Comparison Field |
WIN Consortium in cancer...Main Company |
Drug Discovery & Dev...View Profile |
SyncBio TechnologiesView Profile |
MicrobioticaView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 0 | 0 | 2016 |
|
Company Size
|
— | 51-200 | 2-10 | 11-50 |
|
City
|
Villejuif, Val de Marne | Cleveland, Ohio | Cambridge, Cambridgeshire | |
|
Country
|
United States | United Kingdom | ||
|
Skills & Keywords
Comparing with main company
|
18 Total Skills
Precision Oncology
Cancer Research
Personalized Medicine
Clinical Trials
Genomics
Biomarkers
Healthcare Innovation
Innovative Worldwide Clinical Trials & Scientific Projects
Cross-Sector Networking
Global Collaboration
Pharma
Bioinformatics
Research
Oncology
Personalized Cancer Medicine
Proteomics
Diagnostics
Biotech
|
43 Total
1 Common
42 Unique
Match
6%
Common Skills:
Clinical Trials
Unique Skills:
Artificial Intelligence
Big Pharma
BioPharma
Biopharmaceuticals
BioTech
Biotechnology
+36
|
40 Total
1 Common
39 Unique
Match
6%
Common Skills:
Cancer Research
Unique Skills:
ACMG
App Development
Artificial Intelligence
Biomedicine
Biostatistics
Biotechnology
+33
|
9 Total
1 Common
8 Unique
Match
6%
Common Skills:
Clinical Trials
Unique Skills:
Cancer
Cell Biology
IBD
Immuno-oncology
Microbiology
Microbiome
+2
|
Other organizations in the same industry
This company is also known as